ultravist 370 solution
bayer inc - iopromide - solution - 77% - iopromide 77% - roentgenography
ultravist 300 injection 300 mg iodineml
bayer (south east asia) pte ltd - iopromide eqv iodine - injection - 623.40 mg - iopromide eqv iodine 300 mg/ml
ultravist 370 injection 370 mg iodineml
bayer (south east asia) pte ltd - iopromide eqv iodine - injection - 768.86 mg - iopromide eqv iodine 370 mg/ml
ultravist 300 solution for injection/infusion
bayer pharma ag bayer pharma ag 13342 berlin germany - iopromide - solution for injection/infusion - 1 ml contains 623 mg iopromide (equivalent to 300 - contrast media - non-iodinated x-ray contrast
ultravist 370 solution for injection/infusion
bayer pharma ag bayer pharma ag 13353 berlin germany - iopromide - solution for injection/infusion - 1 ml contains 769 mg iopromide (equivalent to 370 - contrast media - iodinated x-raycontrast media:
ultravist 150
bayer new zealand limited - iopromide 312 mg/ml equivalent to iodine 150 mg/ml - solution for infusion - 150 mg/ml - active: iopromide 312 mg/ml equivalent to iodine 150 mg/ml excipient: hydrochloric acid sodium calcium edetate trometamol water for injection
ultravist 300
bayer co. (malaysia) sdn. bhd. - iopromide -
ultravist 370
bayer co. (malaysia) sdn. bhd. - iopromide -
ultravist 370 (100ml)
bayer co. (malaysia) sdn. bhd. - iopromide -
ultravist 300 (100ml)
bayer co. (malaysia) sdn. bhd. - iopromide -